These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11948455)

  • 1. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells.
    Eshel R; Zanin A; Kapon D; Sagi-Assif O; Brakenhoff R; van Dongen G; Witz IP
    Int J Cancer; 2002 Apr; 98(6):803-10. PubMed ID: 11948455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.
    Eshel R; Zanin A; Sagi-Assif O; Meshel T; Smorodinsky NI; Dwir O; Alon R; Brakenhoff R; van Dongen G; Witz IP
    J Biol Chem; 2000 Apr; 275(17):12833-40. PubMed ID: 10777581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.
    Nieuwenhuis EJ; Leemans CR; Kummer JA; Denkers F; Snow GB; Brakenhoff RH
    Lab Invest; 2003 Aug; 83(8):1233-40. PubMed ID: 12920252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion.
    Brakenhoff RH; Gerretsen M; Knippels EM; van Dijk M; van Essen H; Weghuis DO; Sinke RJ; Snow GB; van Dongen GA
    J Cell Biol; 1995 Jun; 129(6):1677-89. PubMed ID: 7790363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.
    de Nooij-van Dalen AG; van Dongen GA; Smeets SJ; Nieuwenhuis EJ; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 2003 Mar; 103(6):768-74. PubMed ID: 12516096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins.
    Witz IP
    J Cell Biochem Suppl; 2000; 34():61-6. PubMed ID: 10762016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.
    Zipin A; Israeli-Amit M; Meshel T; Sagi-Assif O; Yron I; Lifshitz V; Bacharach E; Smorodinsky NI; Many A; Czernilofsky PA; Morton DL; Witz IP
    Cancer Res; 2004 Sep; 64(18):6571-8. PubMed ID: 15374970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links.
    Wenzel CT; Scher RL; Richtsmeier WJ
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1279-86. PubMed ID: 7576475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
    Bran G; Götte K; Riedel K; Hörmann K; Riedel F
    In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
    Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
    Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
    Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.
    Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA
    Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the murine Ly-6A/E antigen homolog of human squamous cell carcinoma antigen E48 during malignant transformation and tumor progression of squamous cell carcinoma line Pam 212.
    Kato T; Dong G; Loukinova E; Chen Z; Van Waes C
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):408-11. PubMed ID: 9782003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
    Riedel F; Götte K; Hörmann K; Grandis JR
    Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
    Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.